| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Strategy Officer | SVP Corporate Strategy | SVP Corporate Strategy
1 company
Trencher Daniel is a Chief Strategy Officer at Teladoc Health, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $238K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 18, 2022 | TDOC Teladoc Health, Inc. | SVP Corporate Strategy | Sell | 1,000 | $41.12 | $41,120.00 | -3.5% | -37.6% | -35.8% | |
| Jun 17, 2022 | TDOC Teladoc Health, Inc. | SVP Corporate Strategy | Sell | 1,000 | $29.12 | $29,120.00 | -3.4% | +4.0% | -18.8% | |
| Mar 7, 2022 | TDOC Teladoc Health, Inc. | SVP Corporate Strategy | Sale+OE | 1,642 | $66.74 | $109,582.15 | -5.3% | -45.7% | -60.0% | |
| Mar 3, 2022 | TDOC Teladoc Health, Inc. | SVP Corporate Strategy | Sale+OE | 1,797 | $70.24 | $126,219.48 | -6.3% | -52.8% | -61.1% | |
| Jan 10, 2022 | TDOC Teladoc Health, Inc. | SVP Corporate Strategy | Sale+OE | 2,000 | $81.75 | $163,500.00 | -7.8% | -19.9% | -71.0% | |
| Dec 10, 2021 | TDOC Teladoc Health, Inc. | SVP Corporate Strategy | Sale+OE | 2,000 | $95.77 | $191,540.00 | -7.8% | -35.9% | -71.0% | |
| Nov 10, 2021 | TDOC Teladoc Health, Inc. | SVP Corporate Strategy | Sale+OE | 2,000 | $140.18 | $280,360.00 | -7.8% | -49.0% | -77.4% | |
| Oct 11, 2021 | TDOC Teladoc Health, Inc. | SVP Corporate Strategy | Sale+OE | 2,000 | $131.06 | $262,120.00 | -7.8% | -36.6% | -80.9% | |
| Sep 10, 2021 | TDOC Teladoc Health, Inc. | SVP Corporate Strategy | Sale+OE | 2,000 | $142.96 | $285,920.00 | -7.8% | -33.1% | -76.4% | |
| Aug 10, 2021 | TDOC Teladoc Health, Inc. | SVP Corporate Strategy | Sale+OE | 2,000 | $152.00 | $304,000.00 | -7.8% | -0.4% | -74.3% |